Finity, Inc. company information, Employees & Contact Information

Reflecting on 2024: Conflict, climate and new pathogen strains shaped global disease trends Airfinity

Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people Airfinity

China’s second COVID-19 wave to be smaller than its first peaking at 11 million cases a week, predicts Airfinity Airfinity

‘Tripledemic’ peak in US and UK hospitalisations to be smaller than last year as new COVID waves start in both countries Airfinity

France could see local dengue cases rise 50-fold by 2030 as temperatures rise Airfinity

Democracies are better at managing pandemics than autocracies, according to a new study by Airfinity Airfinity

The West should be on a war footing for the next pandemic Airfinity

Airfinity sponsors Team Ocean Warrior, the first ever Scandinavian boat to row across the Mid Pacific Ocean Airfinity

Airfinity launches obesity intelligence solution to forecast and simulate obesity related outcomes Airfinity

Is the world prepared for a potential H5N1 bird flu pandemic? Airfinity

Airfinity’s COVID-19 forecast for China infections and deaths Airfinity

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir Airfinity

Stockpiles worth $1.1 billion of COVID-19 antiviral pill Paxlovid have expired in UK and Europe Airfinity

Wegovy costs $1.3m to prevent one heart attack, stroke, or cardiovascular death Airfinity

US FDA has extended the PDUFA target date for Legend Biotech/Janssen’s Cilta-Cel from November 29, 2021, to February 28, 2022. Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases Airfinity

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market Airfinity

Elderly RSV vaccines to generate $10.5B annually by 2030 in G7 countries Airfinity

A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8% Airfinity

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers Airfinity

GSK releases positive data on its RSV vaccine for older adults, RSV OA Airfinity

300% rise in approved new cancer treatments in the last two decades, with US cancer moonshot goal achievable by 2048 Airfinity

COVID-19 vaccine makers raise prices to off set falling revenue as demand for jabs drops Airfinity

Comparing the burden of COVID-19 to seasonal flu: what does the data say? Airfinity

Airfinity launches new platform IDA to track all infectious disease vaccine and treatment candidates Airfinity

China’s COVID-19 wave forecast to have two peaks where cases could reach 4.2 million a day Airfinity

Global wastage of COVID-19 vaccines could be 1.1 billion doses Airfinity

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination Airfinity

Moderna more effective than Pfizer in direct comparison against the Delta variant Airfinity

China risks between 1.3 and 2.1 million deaths if it ends its zero-COVID strategy Airfinity

Oncopeptides withdraws its peptide-drug conjugate (PCD) Pepaxto from the US market Airfinity

COVID-19 vaccine market forecast to grow 29% to $84.9B in 2022, according to Airfinity Airfinity

Finity launches new AI powered classification software platform - Classifi | News and Insights - Finity Consulting finity.com.au

AstraZeneca’s infant RSV drug Beyfortus could generate $1.1bn sales revenue Airfinity

St. Thomas’ New Marriott Resort Is Powered by Clean Energy Caribbean Journal

Why even the smartest AI is missing the name game Forbes Australia

Finity and Ortec Finance partner to offer advanced climate scenario analysis for investment portfolios finity.com.au

The Pulsepoint Platform finity.com.au

Capstone Green Energy (NASDAQ:CGRN) Distributor E-Finity Secures 2.4 Megawatt Order to Power Major Caribbean Resort FinancialContent

Classifi | Products finity.com.au

Chintan Sapariya: growth as an actuary finity.com.au

Case study: How Uniwriter helps businesses finity.com.au

Portia Elliott: balancing traditional actuarial and climate work finity.com.au

Navigating the Insurtech Landscape finity.com.au

Sophie Howard: "where people want to be" finity.com.au

Finity launches new cloud-based end-to-end underwriting platform – Uniwriter | News and Insights - Finity Consulting finity.com.au

Optima In Focus Webinar: Commercial Lines - a summary finity.com.au

Meet Finity Principal Adam Payne | News and Insights - Finity Consulting finity.com.au

Australia’s first National Climate Risk Assessment finity.com.au

Corporate social responsibility finity.com.au

Commitment to diversity, equality and inclusion finity.com.au

Finity Consulting finity.com.au

Reconciliation Action Plan finity.com.au

Finity Graduate Program 2025 | Careers finity.com.au

Actuarial & Analytics Graduates | Careers finity.com.au

Vantage allows intermediated insurers to finity.com.au

Forced Adoption in Australia finity.com.au

Risk management insights for private health insurers finity.com.au

Injury & care schemes finity.com.au

Mutual bank mergers: an inevitable trend? | News and Insights finity.com.au

NSW Floods – a delicate balance finity.com.au

Physical Climate Risk Assessment for the Local Aboriginal Land Council in Brewarrina: A pro-bono project, part of Finity’s Reconciliation Action Plan | News and Insights finity.com.au

Winds of change in the NDIS: what does it mean for injury schemes? finity.com.au

The Cost of Mental Injury Claims in Queensland finity.com.au